Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenetic Biosciences (XBIO) Return on Capital Employed (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Return on Capital Employed for 5 consecutive years, with 0.81% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed fell 23.0% year-over-year to 0.81%, compared with a TTM value of 0.81% through Sep 2025, down 23.0%, and an annual FY2024 reading of 0.53%, changed N/A over the prior year.
  • Return on Capital Employed was 0.81% for Q3 2025 at Xenetic Biosciences, down from 0.7% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.15% in Q1 2023 and bottomed at 0.81% in Q3 2025.
  • Average Return on Capital Employed over 3 years is 0.51%, with a median of 0.58% recorded in 2024.
  • The sharpest move saw Return on Capital Employed crashed -49bps in 2024, then dropped -4bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.43% in 2023, then plummeted by -48bps to 0.64% in 2024, then decreased by -26bps to 0.81% in 2025.
  • Business Quant data shows Return on Capital Employed for XBIO at 0.81% in Q3 2025, 0.7% in Q2 2025, and 0.68% in Q1 2025.